ADVERTISEMENT
News
FDA Recalls Nystatin Oral Suspension
04/11/2019
The recall affects bottles from lot 356527 (Exp. 3/19), which were distributed in Arkansas and Mississippi.
Akorn voluntarily initiated the recall March 28, 2019. On April 4, 2019, the FDA designated it Class III. Under the recall classification, use of the affected product is not likely to cause harm.
Nystatin oral suspension is available with a prescription to treat fungal infections of the mouth.
—Jolynn Tumolo